Acarbose
Furazolidone may increase the hypoglycemic activities of Acarbose.
Acebutolol
Furazolidone may increase the hypotensive activities of Acebutolol.
Albiglutide
Furazolidone may increase the hypoglycemic activities of Albiglutide.
Advertisement
Albuterol
The risk or severity of adverse effects can be increased when Furazolidone is combined with Salbutamol.
Alfentanil
Furazolidone may increase the central nervous system depressant (CNS depressant) and hypertensive activities of Alfentanil.
Aliskiren
Furazolidone may increase the hypotensive activities of Aliskiren.
Advertisement
Almotriptan
The metabolism of Almotriptan can be decreased when combined with Furazolidone.
Alogliptin
Furazolidone may increase the hypoglycemic activities of Alogliptin.
Alphaprodine
The risk or severity of adverse effects can be increased when Alphaprodine is combined with Furazolidone.
Advertisement
Alprenolol
Furazolidone may increase the hypotensive activities of Alprenolol.
Altretamine
Altretamine may increase the orthostatic hypotensive activities of Furazolidone.
Ambrisentan
Furazolidone may increase the hypotensive activities of Ambrisentan.
Amineptin
Furazolidone may increase the serotonergic activities of Amineptine.
Amitriptyline
Furazolidone may increase the serotonergic activities of Amitriptyline.
Amlodipine
Furazolidone may increase the hypotensive activities of Amlodipine.
Amoxapine
Furazolidone may increase the serotonergic activities of Amoxapine.
Amphetamine
Furazolidone may increase the hypertensive activities of Amphetamine.
Apomorphine
The metabolism of Apomorphine can be decreased when combined with Furazolidone.
Apraclonidine
The risk or severity of adverse effects can be increased when Furazolidone is combined with Apraclonidine.
Arbutamine
The risk or severity of adverse effects can be increased when Furazolidone is combined with Arbutamine.
Arformoterol
The risk or severity of adverse effects can be increased when Furazolidone is combined with Arformoterol.
Atenolol
Furazolidone may increase the hypotensive activities of Atenolol.
Atomoxetine
Furazolidone may increase the central neurotoxic activities of Atomoxetine.
Atropine
Furazolidone may increase the hypertensive activities of Atropine.
Bambuterol
The risk or severity of adverse effects can be increased when Furazolidone is combined with Bambuterol.
Benazepril
Furazolidone may increase the hypotensive activities of Benazepril.
Bendroflumethiazide
Furazolidone may increase the hypotensive activities of Bendroflumethiazide.
Benzphetamine
Furazolidone may increase the hypertensive activities of Benzphetamine.
Bepridil
Furazolidone may increase the hypotensive activities of Bepridil.
BETAHISTINE
The serum concentration of Betahistine can be increased when it is combined with Furazolidone.
Betaxolol
Furazolidone may increase the hypotensive activities of Betaxolol.
Bethanidine
Furazolidone may increase the hypotensive activities of Bethanidine.
Bezafibrate
The risk or severity of adverse effects can be increased when Furazolidone is combined with Bezafibrate.
Bimatoprost
Furazolidone may increase the hypotensive activities of Bimatoprost.
Bisoprolol
Furazolidone may increase the hypotensive activities of Bisoprolol.
Bosentan
Furazolidone may increase the hypotensive activities of Bosentan.
Bretylium
Furazolidone may increase the hypotensive activities of Bretylium.
Brimonidine
The risk or severity of adverse effects can be increased when Furazolidone is combined with Brimonidine.
Bromocriptine
The metabolism of Bromocriptine can be decreased when combined with Furazolidone.
Bupranolol
Furazolidone may increase the hypotensive activities of Bupranolol.
Buprenorphine
The risk or severity of adverse effects can be increased when Buprenorphine is combined with Furazolidone.
Bupropion
The risk or severity of adverse effects can be increased when Furazolidone is combined with Bupropion.
Buspirone
The risk or severity of adverse effects can be increased when Furazolidone is combined with Buspirone.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Furazolidone.
Cabergoline
The metabolism of Cabergoline can be decreased when combined with Furazolidone.
Cafedrine
Furazolidone may increase the hypotensive activities of Cafedrine.
Canagliflozin
Furazolidone may increase the hypoglycemic activities of Canagliflozin.
Canagliflozin Anhydrous
Furazolidone may increase the hypoglycemic activities of Canagliflozin.
Candesartan
Furazolidone may increase the hypotensive activities of Candesartan.
Candesartan Cilexetil
Furazolidone may increase the hypotensive activities of Candesartan cilexetil.
Captopril
Furazolidone may increase the hypotensive activities of Captopril.
Carbamazepine
The risk or severity of adverse effects can be increased when Carbamazepine is combined with Furazolidone.
Carteolol
Furazolidone may increase the hypotensive activities of Carteolol.
Carvedilol
Furazolidone may increase the hypotensive activities of Carvedilol.
Celiprolol
Furazolidone may increase the hypotensive activities of Celiprolol.
Chlorothiazide
Furazolidone may increase the hypotensive activities of Chlorothiazide.
Chlorpropamide
Furazolidone may increase the hypoglycemic activities of Chlorpropamide.
Chlorthalidone
Furazolidone may increase the hypotensive activities of Chlorthalidone.
Cicletanine
Furazolidone may increase the hypotensive activities of Cicletanine.
Cilazapril
Furazolidone may increase the hypotensive activities of Cilazapril.
Citalopram
Furazolidone may increase the serotonergic activities of Citalopram.
Clemastine
Furazolidone may increase the anticholinergic activities of Clemastine.
Clenbuterol
The risk or severity of adverse effects can be increased when Furazolidone is combined with Clenbuterol.
Clomipramine
Furazolidone may increase the serotonergic activities of Clomipramine.
Clonidine
Furazolidone may increase the hypotensive activities of Clonidine.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Furazolidone.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Furazolidone.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Furazolidone.
Cryptenamine
Furazolidone may increase the hypotensive activities of Cryptenamine.
Cyclobenzaprine
Cyclobenzaprine may increase the serotonergic activities of Furazolidone.
Cyclopenthiazide
Furazolidone may increase the hypotensive activities of Cyclopenthiazide.
Cyclothiazide
Furazolidone may increase the hypotensive activities of Cyclothiazide.
Cyproheptadine
Furazolidone may increase the anticholinergic activities of Cyproheptadine.
Dapagliflozin
Furazolidone may increase the hypoglycemic activities of Dapagliflozin.
Debrisoquin
Furazolidone may increase the hypotensive activities of Debrisoquin.
Deserpidine
Furazolidone may increase the hypotensive activities of Deserpidine.
Desipramine
Furazolidone may increase the serotonergic activities of Desipramine.
Desvenlafaxine
Furazolidone may increase the serotonergic activities of Desvenlafaxine.
Deutetrabenazine
The risk or severity of adverse effects can be increased when Furazolidone is combined with Deutetrabenazine.
Dexmethylphenidate
Furazolidone may increase the hypertensive activities of Dexmethylphenidate.
Dextroamphetamine
Furazolidone may increase the hypertensive activities of Dextroamphetamine.
Dextromethorphan
Furazolidone may increase the serotonergic activities of Dextromethorphan.
Dextromoramide
The risk or severity of adverse effects can be increased when Dextromoramide is combined with Furazolidone.
Dezocine
The risk or severity of adverse effects can be increased when Dezocine is combined with Furazolidone.
Diazoxide
Furazolidone may increase the hypotensive activities of Diazoxide.
Diethylpropion
Furazolidone may increase the hypertensive activities of Diethylpropion.
Dihydralazine
Furazolidone may increase the hypotensive activities of Dihydralazine.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Furazolidone.
Dihydroergotamine
The metabolism of Dihydroergotamine can be decreased when combined with Furazolidone.
Diltiazem
Furazolidone may increase the hypotensive activities of Diltiazem.
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Furazolidone.
Dipivefrin
The risk or severity of adverse effects can be increased when Furazolidone is combined with Dipivefrin.
Disopyramide
Furazolidone may increase the hypoglycemic activities of Disopyramide.
Disulfiram
The risk or severity of convulsion can be increased when Furazolidone is combined with Disulfiram.
Dobutamine
The risk or severity of adverse effects can be increased when Furazolidone is combined with Dobutamine.
Domperidone
The risk or severity of adverse effects can be increased when Furazolidone is combined with Domperidone.
Dorzolamide
Furazolidone may increase the hypotensive activities of Dorzolamide.
Dothiepin
Furazolidone may increase the serotonergic activities of Dosulepin.
Doxapram
Furazolidone may increase the hypertensive activities of Doxapram.
Doxazosin
Furazolidone may increase the hypotensive activities of Doxazosin.
Doxepin
Furazolidone may increase the serotonergic activities of Doxepin.
Doxylamine
Furazolidone may increase the anticholinergic activities of Doxylamine.
Droxidopa
The risk or severity of adverse effects can be increased when Furazolidone is combined with Droxidopa.
Dulaglutide
Furazolidone may increase the hypoglycemic activities of Dulaglutide.
Duloxetine
Furazolidone may increase the serotonergic activities of Duloxetine.
Eletriptan
The metabolism of Eletriptan can be decreased when combined with Furazolidone.
Empagliflozin
Furazolidone may increase the hypoglycemic activities of Empagliflozin.
Enalapril
Furazolidone may increase the hypotensive activities of Enalapril.
Enalaprilat
Furazolidone may increase the hypotensive activities of Enalaprilat.
Enalaprilat Anhydrous
Furazolidone may increase the hypotensive activities of Enalaprilat.
Entacapone
The risk or severity of adverse effects can be increased when Entacapone is combined with Furazolidone.
Epinephrine
Furazolidone may increase the hypertensive activities of Epinephrine.
Epoprostenol
Furazolidone may increase the hypotensive activities of Epoprostenol.
Eprosartan
Furazolidone may increase the hypotensive activities of Eprosartan.
Ergotamine
Furazolidone may increase the hypertensive activities of Ergotamine.
Escitalopram
Furazolidone may increase the serotonergic activities of Escitalopram.
Ethanol
The risk or severity of adverse effects can be increased when Ethanol is combined with Furazolidone.
Ethylmorphine
The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Furazolidone.
Exenatide
Furazolidone may increase the hypoglycemic activities of Exenatide.
Felodipine
Furazolidone may increase the hypotensive activities of Felodipine.
Fenfluramine
Furazolidone may increase the serotonergic activities of Fenfluramine.
Fenoldopam
Furazolidone may increase the hypotensive activities of Fenoldopam.
Fenoterol
The risk or severity of adverse effects can be increased when Furazolidone is combined with Fenoterol.
Fentanyl
Furazolidone may increase the central nervous system depressant (CNS depressant) and hypertensive activities of Fentanyl.
Ferulic Acid
Furazolidone may increase the hypotensive activities of Ferulic acid.
Fluoxetine
Furazolidone may increase the serotonergic activities of Fluoxetine.
Fluvoxamine
Furazolidone may increase the serotonergic activities of Fluvoxamine.
Formoterol
The risk or severity of adverse effects can be increased when Furazolidone is combined with Formoterol.
Fosinopril
Furazolidone may increase the hypotensive activities of Fosinopril.
Frovatriptan
The metabolism of Frovatriptan can be decreased when combined with Furazolidone.
Gliclazide
Furazolidone may increase the hypoglycemic activities of Gliclazide.
Glimepiride
Furazolidone may increase the hypoglycemic activities of Glimepiride.
Glipizide
Furazolidone may increase the hypoglycemic activities of Glipizide.
Glyburide
Furazolidone may increase the hypoglycemic activities of Glyburide.
Guanabenz
Furazolidone may increase the hypotensive activities of Guanabenz.
Guanadrel
Furazolidone may increase the hypotensive activities of Guanadrel.
Guanethidine
Furazolidone may increase the hypotensive activities of Guanethidine.
Guanfacine
Furazolidone may increase the hypotensive activities of Guanfacine.
Heroin
The risk or severity of adverse effects can be increased when Heroin is combined with Furazolidone.
Hydralazine
Furazolidone may increase the hypotensive activities of Hydralazine.
Hydrochlorothiazide
Furazolidone may increase the hypotensive activities of Hydrochlorothiazide.
Hydrocodone
The risk or severity of adverse effects can be increased when Hydrocodone is combined with Furazolidone.
HYDROCODONE POLISTIREX
The risk or severity of adverse effects can be increased when Hydrocodone is combined with Furazolidone.
Hydroflumethiazide
Furazolidone may increase the hypotensive activities of Hydroflumethiazide.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Furazolidone.
Imidapril
Furazolidone may increase the hypotensive activities of Imidapril.
Imipramine
Furazolidone may increase the serotonergic activities of Imipramine.
Indacaterol
The risk or severity of adverse effects can be increased when Furazolidone is combined with Indacaterol.
Indapamide
Furazolidone may increase the hypotensive activities of Indapamide.
Indoramin
Furazolidone may increase the hypotensive activities of Indoramin.
Insulin Detemir
Furazolidone may increase the hypoglycemic activities of Insulin Detemir.
Insulin Glargine
Furazolidone may increase the hypoglycemic activities of Insulin Glargine.
insulin human, rDNA origin
Furazolidone may increase the hypoglycemic activities of Insulin Human.
Insulin Lispro
Furazolidone may increase the hypoglycemic activities of Insulin Lispro.
Insulin, Aspart Protamine, Human
Furazolidone may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Aspart, Human
Furazolidone may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Glulisine, Human
Furazolidone may increase the hypoglycemic activities of Insulin Glulisine.
Insulin, Protamine Lispro, Human
Furazolidone may increase the hypoglycemic activities of Insulin Lispro.
Iproniazid
Iproniazid may increase the hypertensive activities of Furazolidone.
Irbesartan
Furazolidone may increase the hypotensive activities of Irbesartan.
Isocarboxazid
Isocarboxazid may increase the hypertensive activities of Furazolidone.
Isoetharine
The risk or severity of adverse effects can be increased when Furazolidone is combined with Isoetarine.
Isometheptene
The risk or severity of adverse effects can be increased when Furazolidone is combined with Isometheptene.
Isoproterenol
The risk or severity of adverse effects can be increased when Furazolidone is combined with Isoprenaline.
Isradipine
Furazolidone may increase the hypotensive activities of Isradipine.
Ketanserin
Furazolidone may increase the hypotensive activities of Ketanserin.
Labetalol
Furazolidone may increase the hypotensive activities of Labetalol.
Lacidipine
Furazolidone may increase the hypotensive activities of Lacidipine.
Latanoprost
Furazolidone may increase the hypotensive activities of Latanoprost.
Lercanidipine
Furazolidone may increase the hypotensive activities of Lercanidipine.
Levalbuterol
The risk or severity of adverse effects can be increased when Furazolidone is combined with Levosalbutamol.
Levodopa
The risk or severity of adverse effects can be increased when Levodopa is combined with Furazolidone.
Levomethadyl
The risk or severity of adverse effects can be increased when Levomethadyl Acetate is combined with Furazolidone.
Levomilnacipran
Furazolidone may increase the serotonergic activities of Levomilnacipran.
Levonordefrin
Furazolidone may increase the hypertensive activities of Levonordefrin.
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Furazolidone.
Linezolid
The risk or severity of adverse effects can be increased when Furazolidone is combined with Linezolid.
Liraglutide
Furazolidone may increase the hypoglycemic activities of Liraglutide.
Lisdexamfetamine
Furazolidone may increase the hypertensive activities of Lisdexamfetamine.
Lisdexamfetamine Dimesylate
Furazolidone may increase the hypertensive activities of Lisdexamfetamine.
Lisinopril
Furazolidone may increase the hypotensive activities of Lisinopril.
Lisinopril Anhydrous
Furazolidone may increase the hypotensive activities of Lisinopril.
Lisuride
The metabolism of Lisuride can be decreased when combined with Furazolidone.
Lithium
The risk or severity of adverse effects can be increased when Furazolidone is combined with Lithium.
Lithium Cation
The risk or severity of adverse effects can be increased when Furazolidone is combined with Lithium.
Lofexidine
Furazolidone may increase the hypotensive activities of Lofexidine.
Losartan
Furazolidone may increase the hypotensive activities of Losartan.
Macitentan
Furazolidone may increase the hypotensive activities of Macitentan.
Manidipine
Furazolidone may increase the hypotensive activities of Manidipine.
Maprotiline
The risk or severity of adverse effects can be increased when Furazolidone is combined with Maprotiline.
Mecamylamine
Furazolidone may increase the hypotensive activities of Mecamylamine.
Mecasermin
Furazolidone may increase the hypoglycemic activities of Mecasermin.
Mecasermin Rinfabate
Furazolidone may increase the hypoglycemic activities of Mecasermin.
Meperidine
Furazolidone may increase the hypotensive and central nervous system depressant (CNS depressant) activities of Pethidine.
Mephentermine
Furazolidone may increase the hypertensive activities of Mephentermine.
Mequitazine
Furazolidone may increase the anticholinergic activities of Mequitazine.
Metaproterenol
The risk or severity of adverse effects can be increased when Furazolidone is combined with Orciprenaline.
Metaraminol
Furazolidone may increase the hypertensive activities of Metaraminol.
Metformin
Furazolidone may increase the hypoglycemic activities of Metformin.
Methadone
The risk or severity of adverse effects can be increased when Furazolidone is combined with Methadone.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Methadyl Acetate is combined with Furazolidone.
Methamphetamine
Furazolidone may increase the hypertensive activities of Methamphetamine.
Methoxamine
Furazolidone may increase the hypertensive activities of Methoxamine.
Methyldopa
The risk or severity of hypertension can be increased when Furazolidone is combined with Methyldopa.
METHYLDOPA ANHYDROUS
The risk or severity of hypertension can be increased when Furazolidone is combined with Methyldopa.
Methylene blue
Furazolidone may increase the serotonergic activities of Methylene blue.
Methylphenidate
Furazolidone may increase the hypertensive activities of Methylphenidate.
Metipranolol
Furazolidone may increase the hypotensive activities of Metipranolol.
Metolazone
Furazolidone may increase the hypotensive activities of Metolazone.
Metoprolol
Furazolidone may increase the hypotensive activities of Metoprolol.
Metyrosine
Furazolidone may increase the hypotensive activities of Metyrosine.
Mianserin
The risk or severity of adverse effects can be increased when Furazolidone is combined with Mianserin.
Mibefradil
Furazolidone may increase the hypotensive activities of Mibefradil.
Midodrine
Furazolidone may increase the hypertensive activities of Midodrine.
Mifepristone
Furazolidone may increase the hypoglycemic activities of Mifepristone.
Miglitol
Furazolidone may increase the hypoglycemic activities of Miglitol.
Milnacipran
Furazolidone may increase the serotonergic activities of Milnacipran.
Minaprine
Minaprine may increase the hypertensive activities of Furazolidone.
Minoxidil
Furazolidone may increase the hypotensive activities of Minoxidil.
Mirtazapine
The risk or severity of adverse effects can be increased when Furazolidone is combined with Mirtazapine.
Moclobemide
The risk or severity of adverse effects can be increased when Furazolidone is combined with Moclobemide.
Moexipril
Furazolidone may increase the hypotensive activities of Moexipril.
Morphine
The therapeutic efficacy of Morphine can be increased when used in combination with Furazolidone.
Moxonidine
Furazolidone may increase the hypotensive activities of Moxonidine.
Nadolol
Furazolidone may increase the hypotensive activities of Nadolol.
Nalbuphine
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Furazolidone.
Naratriptan
The metabolism of Naratriptan can be decreased when combined with Furazolidone.
Nateglinide
Furazolidone may increase the hypoglycemic activities of Nateglinide.
Nebivolol
Furazolidone may increase the hypotensive activities of Nebivolol.
Nefazodone
Furazolidone may increase the serotonergic activities of Nefazodone.
Nialamide
Nialamide may increase the hypertensive activities of Furazolidone.
Nicardipine
Furazolidone may increase the hypotensive activities of Nicardipine.
Nicorandil
Furazolidone may increase the hypotensive activities of Nicorandil.
Nilvadipine
Furazolidone may increase the hypotensive activities of Nilvadipine.
Nimodipine
Furazolidone may increase the hypotensive activities of Nimodipine.
Nisoldipine
Furazolidone may increase the hypotensive activities of Nisoldipine.
Nitrendipine
Furazolidone may increase the hypotensive activities of Nitrendipine.
Nitroprusside
Furazolidone may increase the hypotensive activities of Nitroprusside.
Norepinephrine
Furazolidone may increase the hypertensive activities of Norepinephrine.
Normethadone
The risk or severity of adverse effects can be increased when Normethadone is combined with Furazolidone.
Nortriptyline
Furazolidone may increase the serotonergic activities of Nortriptyline.
Olanzapine
Furazolidone may increase the serotonergic activities of Olanzapine.
Olmesartan
Furazolidone may increase the hypotensive activities of Olmesartan.
Olodaterol
The risk or severity of adverse effects can be increased when Furazolidone is combined with Olodaterol.
Opipramol
Furazolidone may increase the serotonergic activities of Opipramol.
Opium
The risk or severity of adverse effects can be increased when Opium is combined with Furazolidone.
Oxprenolol
Furazolidone may increase the hypotensive activities of Oxprenolol.
Oxycodone
The risk or severity of adverse effects can be increased when Furazolidone is combined with Oxycodone.
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Furazolidone.
p-Hydroxyamphetamine
Furazolidone may increase the hypertensive activities of Hydroxyamphetamine.
Paregoric
The therapeutic efficacy of Morphine can be increased when used in combination with Furazolidone.
Pargyline
Pargyline may increase the hypertensive activities of Furazolidone.
Paroxetine
Furazolidone may increase the serotonergic activities of Paroxetine.
Penbutolol
Furazolidone may increase the hypotensive activities of Penbutolol.
Pentamidine
Furazolidone may increase the hypoglycemic activities of Pentamidine.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Furazolidone.
Pergolide
The metabolism of Pergolide can be decreased when combined with Furazolidone.
Perindopril
Furazolidone may increase the hypotensive activities of Perindopril.
Phenelzine
Phenelzine may increase the hypertensive activities of Furazolidone.
Phenoxybenzamine
Furazolidone may increase the hypotensive activities of Phenoxybenzamine.
Phentermine
Furazolidone may increase the hypertensive activities of Phentermine.
PHENTERMINE RESIN
Furazolidone may increase the hypertensive activities of Phentermine.
Phentolamine
Furazolidone may increase the hypotensive activities of Phentolamine.
Phentolamine Mesylate
Furazolidone may increase the hypotensive activities of Phentolamine.
Phenylephrine
Furazolidone may increase the hypertensive activities of Phenylephrine.
Phenylpropanolamine
The risk or severity of adverse effects can be increased when Furazolidone is combined with Phenylpropanolamine.
Pholcodine
Pholcodine may increase the serotonergic activities of Furazolidone.
Pinacidil
Furazolidone may increase the hypotensive activities of Pinacidil.
Pindolol
Furazolidone may increase the hypotensive activities of Pindolol.
Pioglitazone
Furazolidone may increase the hypoglycemic activities of Pioglitazone.
Pirbuterol
The risk or severity of adverse effects can be increased when Furazolidone is combined with Pirbuterol.
Pirinitramide
The risk or severity of adverse effects can be increased when Piritramide is combined with Furazolidone.
Pizotyline
Furazolidone may increase the anticholinergic activities of Pizotifen.
Polythiazide
Furazolidone may increase the hypotensive activities of Polythiazide.
Pramlintide
Furazolidone may increase the hypoglycemic activities of Pramlintide.
Prazosin
Furazolidone may increase the hypotensive activities of Prazosin.
Procarbazine
Furazolidone may increase the hypertensive activities of Procarbazine.
Procaterol
The risk or severity of adverse effects can be increased when Furazolidone is combined with Procaterol.
Propoxyphene
The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Furazolidone.
Propranolol
Furazolidone may increase the hypotensive activities of Propranolol.
Protriptyline
Furazolidone may increase the serotonergic activities of Protriptyline.
Pseudoephedrine
Furazolidone may increase the hypertensive activities of Pseudoephedrine.
Quinapril
Furazolidone may increase the hypotensive activities of Quinapril.
Quinine
Furazolidone may increase the hypoglycemic activities of Quinine.
Ramipril
Furazolidone may increase the hypotensive activities of Ramipril.
Rasagiline
Rasagiline may increase the hypertensive activities of Furazolidone.
Regular Insulin, Human
Furazolidone may increase the hypoglycemic activities of Insulin Human.
Remifentanil
Furazolidone may increase the central nervous system depressant (CNS depressant) and hypertensive activities of Remifentanil.
Repaglinide
Furazolidone may increase the hypoglycemic activities of Repaglinide.
Rescinnamine
Furazolidone may increase the hypotensive activities of Rescinnamine.
Reserpine
The risk or severity of adverse effects can be increased when Furazolidone is combined with Reserpine.
Rilmenidine
Furazolidone may increase the hypotensive activities of Rilmenidine.
Riociguat
Furazolidone may increase the hypotensive activities of Riociguat.
Ritodrine
The risk or severity of adverse effects can be increased when Furazolidone is combined with Ritodrine.
Rizatriptan
The metabolism of Rizatriptan can be decreased when combined with Furazolidone.
Ropinirole
The metabolism of Ropinirole can be decreased when combined with Furazolidone.
Rosiglitazone
Furazolidone may increase the hypoglycemic activities of Rosiglitazone.
Salmeterol
The risk or severity of adverse effects can be increased when Furazolidone is combined with Salmeterol.
Saxagliptin
Furazolidone may increase the hypoglycemic activities of Saxagliptin.
Saxagliptin Anhydrous
Furazolidone may increase the hypoglycemic activities of Saxagliptin.
Selegiline
Selegiline may increase the hypertensive activities of Furazolidone.
Selexipag
Furazolidone may increase the hypotensive activities of Selexipag.
Sertraline
Furazolidone may increase the serotonergic activities of Sertraline.
Sitagliptin
Furazolidone may increase the hypoglycemic activities of Sitagliptin.
Sitagliptin Phosphate
Furazolidone may increase the hypoglycemic activities of Sitagliptin.
Spirapril
Furazolidone may increase the hypotensive activities of Spirapril.
Sufentanil
Furazolidone may increase the central nervous system depressant (CNS depressant) and hypertensive activities of Sufentanil.
Sulfadiazine
Furazolidone may increase the hypoglycemic activities of Sulfadiazine.
Sulfamethoxazole
Furazolidone may increase the hypoglycemic activities of Sulfamethoxazole.
Sulfisoxazole
Furazolidone may increase the hypoglycemic activities of Sulfisoxazole.
Sumatriptan
The metabolism of Sumatriptan can be decreased when combined with Furazolidone.
Sumatriptan Succinate
The metabolism of Sumatriptan can be decreased when combined with Furazolidone.
Sunitinib
Furazolidone may increase the hypoglycemic activities of Sunitinib.
Talinolol
Furazolidone may increase the hypotensive activities of Talinolol.
Tapentadol
The risk or severity of adverse effects can be increased when Tapentadol is combined with Furazolidone.
Telmisartan
Furazolidone may increase the hypotensive activities of Telmisartan.
Terbutaline
The risk or severity of adverse effects can be increased when Furazolidone is combined with Terbutaline.
Terbutaline Sulfate
The risk or severity of adverse effects can be increased when Furazolidone is combined with Terbutaline.
Terlipressin
Furazolidone may increase the hypotensive activities of Terlipressin.
Testosterone Propionate
The risk or severity of adverse effects can be increased when Testosterone propionate is combined with Furazolidone.
Tetrabenazine
The risk or severity of adverse effects can be increased when Furazolidone is combined with Tetrabenazine.
Tetrahydrozoline
Furazolidone may increase the hypertensive activities of Tetryzoline.
Theodrenaline
Furazolidone may increase the hypotensive activities of Theodrenaline.
Tianeptine
The risk or severity of adverse effects can be increased when Tianeptine is combined with Furazolidone.
Tibolone
Furazolidone may increase the hypotensive activities of Tibolone.
Timolol
Furazolidone may increase the hypotensive activities of Timolol.
Timolol Anhydrous
Furazolidone may increase the hypotensive activities of Timolol.
Tolazamide
Furazolidone may increase the hypoglycemic activities of Tolazamide.
Tolazoline
Furazolidone may increase the hypotensive activities of Tolazoline.
Tolbutamide
Furazolidone may increase the hypoglycemic activities of Tolbutamide.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Furazolidone.
Toloxatone
Toloxatone may increase the hypertensive activities of Furazolidone.
Torsemide
Furazolidone may increase the hypotensive activities of Torasemide.
Tramadol
Tramadol may increase the neuroexcitatory activities of Furazolidone.
Trandolapril
Furazolidone may increase the hypotensive activities of Trandolapril.
Tranylcypromine
Tranylcypromine may increase the hypertensive activities of Furazolidone.
Travoprost
Furazolidone may increase the hypotensive activities of Travoprost.
Trazodone
Furazolidone may increase the serotonergic activities of Trazodone.
Treprostinil
Furazolidone may increase the hypotensive activities of Treprostinil.
Trichlormethiazide
Furazolidone may increase the hypotensive activities of Trichlormethiazide.
Trimethaphan
Furazolidone may increase the hypotensive activities of Trimethaphan.
Trimipramine
Furazolidone may increase the serotonergic activities of Trimipramine.
Tryptophan
L-Tryptophan may increase the serotonergic activities of Furazolidone.
UNOPROSTONE
Furazolidone may increase the hypotensive activities of Unoprostone.
Urapidil
Furazolidone may increase the hypotensive activities of Urapidil.
Valsartan
Furazolidone may increase the hypotensive activities of Valsartan.
Venlafaxine
Furazolidone may increase the serotonergic activities of Venlafaxine.
Vilanterol
The risk or severity of adverse effects can be increased when Furazolidone is combined with Vilanterol.
Vilazodone
The metabolism of Vilazodone can be decreased when combined with Furazolidone.
Vincamine
Furazolidone may increase the hypotensive activities of Vincamine.
Vinpocetine
Furazolidone may increase the hypotensive activities of Vinpocetine.
Vortioxetine
The metabolism of Vortioxetine can be decreased when combined with Furazolidone.
Xylometazoline
Furazolidone may increase the hypotensive activities of Xylometazoline.
Zofenopril
Furazolidone may increase the hypotensive activities of Zofenopril.
Zolmitriptan
The metabolism of Zolmitriptan can be decreased when combined with Furazolidone.
